Header image

Funding your life science business: How to navigate the opportunities offered by dilutive and non-dilutive funding

Tracks
Track 3
Thursday, October 31, 2024
11:50 AM - 12:35 PM
Room 110

Overview

Sponsored by: PRIME


Details

There has never been a better time to pursue life science innovation in Australia. Governments are investing through a range of funding opportunities at both state and federal levels to directly and indirectly support the research and SME sector and are increasingly creating dilutive funding opportunities alongside traditional grants. With opportunity comes complexity. It is important for any business and research organisation contemplating seeking external investment to understand both the requirements of the investor, to maximise changes of success, as well as the implications of success. Considerations such as equity dilution, impacts on eligibility for other incentives, and compliance requirements are important to understand upfront. Our panel session will help to demystify some of these complexities and help the audience navigate the incentive landscape with confidence.


Speaker

Agenda Item Image
Mr Bruce Bayley
Partner
SPP

Chair

Agenda Item Image
Dr Marthe D'Ombrain
Executive Director & Head, Global Research Innovation
CSL

Panellist

Dr. Anne-Laure Puaux
Head of Business Development & CEO WEHI Ventures
WEHI

Panellist

Agenda Item Image
Ms Simone Quin
Partner
Prime Financial Group

Panellist

loading